A Study of Flexible or Fixed Dose LY2216684 as Adjunctive Treatment for Participants With Major Depressive Disorder Who Have Had a Partial Response to Selective Serotonin Reuptake Inhibitor (SSRI) Treatment
Clinical trial NCT01187407 · COMPLETED
Trial details
- NCT number
- NCT01187407
- Sponsor
- Eli Lilly and Company
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2011-03-01
- Primary completion
- 2013-08-01
- Enrollment
- 1480
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.